Matrix metalloproteinases of epithelial origin in facial sebum of patients with acne and their regulation by isotretinoin

Journal of Investigative Dermatology

Volumn 125, Issue 4, 2005, Pages 673-684

  Papakonstantinou, Eleni ^a   Aletras, Alexios J ^b   Glass, Evelyn ^c   Tsogas, Panagiotis ^a   Dionyssopoulos, Alexander ^a   Adjaye, James ^d   Fimmel, Sabine ^c   Gouvousis, Panagiotis ^b   Herwig, Ralf ^d   Lehrach, Hans ^d   Zouboulis, Christos C ^c   Karakiulakis, George ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Acne; Isotretinoin; Keratinocytes; MMP; Sebocytes; TIMP

Indexed keywords

ARACHIDONIC ACID; COLLAGENASE; COLLAGENASE 3; GELATINASE; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; ISOTRETINOIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ACNE; ACNE VULGARIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; INFLAMMATION; KERATINOCYTE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REDUCTION; SEBACEOUS GLAND; SEBACEOUS GLAND DISEASE; SEBUM; WESTERN BLOTTING; ZYMOGRAPHY; ADOLESCENT; BACTERIUM; CELL CULTURE; CYTOLOGY; ENZYMOLOGY; FACE; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ACNE VULGARIS; ADOLESCENT; BACTERIA; BLOTTING, WESTERN; CELLS, CULTURED; COLLAGENASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACE; FEMALE; GELATINASES; HUMANS; ISOTRETINOIN; KERATINOCYTES; MATRIX METALLOPROTEINASES; RNA, MESSENGER; SEBUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 27744571727     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23848.x     Document Type: Article

References (56)

1. Adjaye J, Herwig R, Herrmann D, et al: Cross-species hybridisation of human and bovine orthologous genes on high density cDNA microarrays. BMC Genomics 5:83, 2004
2. Axel DI, Frigge A, Dittmann J, et al: All-trans retinoic acid regulates proliferation, migration, differentiation, and extracellular matrix turnover of human arterial smooth muscle cells. Cardiovascular Res 49:851-862, 2001
3. Baumann P, Zigrino P, Mauch C, Breitkreutz D, Nischt R: Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes. Br J Cancer 83:1387-1393, 2000
4. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771, 1988
5. Braunhut SJ, Moses MA: Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). J Biol Chem 269:13472-13479, 1994
6. Burger D, Begue-Pastor N, Benavent S: The active metabolite of leflunomide, A77 1726, inhibits the production of prostaglandin E(2), matrix metalloproteinase 1 and interleukin 6 in human fibroblast-like synoviocytes. Rheumatology 42:89-96, 2003
7. Cao J, Sato H, Takino T, Seiki M: The C-terminal region of membrane type matrix metalloproteinase is a functional trans-membrane domain required for pro-gelatinase A activation. J Biol Chem 270:801-805, 1995
8. Choi BK, Lee HJ, Kang JH, Jeong GJ, Min CK, Yoo YJ: Induction of osteoclastogenesis and matrix metalloproteinase expression by the lipooligosaccharide of Treponema denticola. Infect Immun 71:226-233, 2003
9. Cipollone F, Iezzi A, Fazia M, et al: The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: Role of glycemic control. Circulation 108:1070-1077, 2003
10. Cussac D, Schaak S, Denis C, Paris H: alpha 2B-adrenergic receptor activates MAPK via a pathway involving arachidonic acid metabolism, matrix metalloproteinases, and epidermal growth factor receptor transactivation. J Biol Chem 277:19882-19888, 2002
11. Devy L, Hollender P, Munaut C, et al: Matrix and serine protease expression during leukemic cell differentiation induced by aclacinomycin and all-trans-retinoic acid. Biochem Pharmacol 63:179-189, 2002
12. Fisher GJ, Voorhees JJ: Molecular mechanisms of retinoid actions in skin. FASEB J 10:1002-1013, 1996
13. Fleischmajer R, Kuroda K, Hazan R, et al: Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2. J Invest Dermatol 115:771-777, 2000
14. Frankenberger M, Hauck RW, Frankenberger B, Haussinger K, Maier KL, Heyder J, Ziegler-Heitbrock HW: All trans-retinoic acid selectively down-regulates matrix metalloproteinase-9 (MMP-9) and up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) in human bronchoalveolar lavage cells. Mol Med 7:263-270, 2001
15. Giambernardi TA, Grant GM, Taylor GP, Hay RJ, Maher VM, McCormick JJ, Klebe RJ: Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol 16:483-496, 1998
16. Gollnick H, Cunliffe W, Berson D, et al: Global alliance to improve outcomes in acne. Management of acne: A report from a Global Alliance to improve outcomes in acne. J Am Acad Dermatol 49:S1-37, 2003
17. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP: Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 74:111-122, 1997
18. Hanemaaijer R, Visser H, Konttinen YT, Koolwijk P, Verheijen JH: A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: Saliva from patients with Sjogren's syndrome contain increased latent and active gelatinase-B levels. Matrix Biol 17:657-665, 1998
19. Herwig R, Aanstad P, Clark M, Lehrach H: Statistical evaluation of differential expression on cDNA nylon arrays with replicated experiments. Nucleic Acids Res 29:E117, 2001
20. Itoh Y, Binner S, Nagase H: Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem J 308:645-651, 1995
21. Jacob K, Wach F, Holzapfel U, Hein R, Lengyel E, Buettner R, Bosserhoff AK: In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Melanoma Res 8:211-219, 1998
22. Jimenez MJ, Balbin M, Alvarez J, et al: A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation. J Cell Biol 155:1333-1344, 2001
23. Karakiulakis G, Missirlis E, Aletras A, Maragoudakis M: Degradation of intact basement membranes by human and murine tumor enzymes. Biochim Biophys Acta 967:163-175, 1988
24. Karakiulakis G, Papanikolaou C, Jankovic SM, Aletras A, Papakonstantinou E, Vretou E, Mirtsou-Fidani V: Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon. Invasion Metastasis 17:158-168, 1997
25. Kerkela E, Saarialho-Kere U: Matrix metalloproteinases in tumor progression: Focus on basal and squamous cell skin cancer. Exp Dermatol 12:109-125, 2003
26. Kobayashi T, Hattori S, Nagai Y, Tajima S: Differential regulation of the secretions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 from human keratinocytes in culture. IUBMB Life 50:221-226, 2000
27. Konttinen YT, Ainola M, Valleala H, et al: Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: Different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 58:691-697, 1999
28. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
29. Leville CD, Dassow MS, Seabrook GR, Jean-Claude JM, Towne JB, Cambria RA: All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo. J Surg Res 90:183-190, 2000
30. Mao JT, Tashkin DP, Belloni PN, Baileyhealy I, Baratelli F, Roth MD: All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema. Chest 124:1724-1732, 2003
31. Moore BA, Aznavoorian S, Engler JA, Windsor LJ: Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. Biochim Biophys Acta 1502:307-318, 2000
32. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH: Manual of Clinical Microbiology, 7th edn. Washington, DC: American Society for Microbiology, 1999
33. Neuville P, Yan Z, Gidlof A, et al: Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARalpha-dependent signaling pathway. Arterioscler Thromb Vasc Biol 19:1430-1436, 1999
34. Orfanos CE, Zouboulis ChC, Almond-Roesler B, Geilen CC: Current use and future potential role of retinoids in dermatology. Drugs 53:358-388, 1997
35. Osteen KG, Bruner-Tran KL, Ong D, Eisenberg E: Paracrine mediators of endometrial matrix metalloproteinase expression: Potential targets for progestin-based treatment of endometriosis. Ann N Y Acad Sci 955:139-146, 157-158 & 396-406, 2002
36. Overall CM: Repression of tissue inhibitor of matrix metalloproteinase expression by all-trans-retinoic acid in rat bone cell populations: Comparison with transforming growth factor-beta 1. J Cell Physiol 164:17-25, 1995
37. Papakonstantinou E, Aletras AJ, Roth M, Tamm M, Karakiulakis G: Hypoxia modulates the effects of transforming growth factor-beta isoforms on matrix-formation by primary human lung fibroblasts. Cytokine 24:25-35, 2003
38. Papakonstantinou E, Dionyssopoulos A, Aletras AJ, Pesintzaki C, Minas A, Karakiulakis G: Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis. J Am Acad Dermatol 51:526-533, 2004
39. Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541-573, 1993
40. Syggelos SA, Eleftheriou SC, Giannopoulou E, Panagiotopoulos E, Aletras AJ: Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses. J Rheumatol 28:1319-1329, 2001
41. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979
42. Toyoda M, Morohashi M: Pathogenesis of acne. Med Electron Microsc 34:29-40, 2001
43. Tsang KJ, Crowe DL: Retinoic acid and extracellular matrix inhibition of matrix metalloproteinase 9 expression is mediated by the mitogen activated protein kinase pathway. Int J Oncol 18:369-374, 2001
44. Tsukada M, Schröder M, Seltmann H, Orfanos CE, Zouboulis ChC: High albumin levels restrict the kinetics of 13-cis retinoic acid uptake and intracellular isomerization to all-trans retinoic acid and inhibit its antiproliferative effect on SZ95 sebocytes. J Invest Dermatol 119:182-185, 2002
45. Uchida G, Yoshimura K, Kitano Y, Okazaki M, Harii K: Tretinoin reverses upregulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts. Exp Dermatol 12:35-42, 2003
46. Varani J, Warner RL, Gharaee-Kermani M, et al: Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol 114:480-486, 2000
47. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases-structure, function, and biochemistry. Circ Res 92: 827-839, 2003
48. Wróbel A, Seitmann H, Fimmel S, et al: Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol 120:175-181, 2003
49. Zhu YK, Liu X, Ertl RF, et al: Retinoic acid attenuates cytokine-driven fibroblast degradation of extracellular matrix in three-dimensional culture. Am J Respir Cell Mol Biol 25:620-627, 2001
50. Zouboulis ChC: Is acne vulgaris a genuine inflammatory disease? Dermatology 203:277-279, 2001a
51. Zouboulis ChC: Exploration of retinoid activity and the role of inflammation in acne: Issues affecting future directions for acne therapy. J Eur Acad Dermatol Venereol 15:63-67, 2001b
52. Zouboulis ChC: Retinoids-which dermatological indications will benefit in the near future? Skin Pharmacol Appl Skin Physiol 14:303-315, 2001c
53. Zouboulis ChC, Eady A, Philpott M, Goldsmith LA, Orfanos CE, Cunliffe WC, Rosenfield R: What is the pathogenesis of acne? Exp Dermatol 14:143-152, 2005
54. Zouboulis ChC, Fimmel S, Ortmann J, Turnbull JR, Boschnakow A: Sebaceous glands. In: Hoath SB, Maibach HI (eds). Neonatal Skin-Structure and Function, 2nd edn. New York: Marcel Dekker, 2003; p 59-88
55. Zouboulis ChC, Orfanos CE: Retinoids. In: Millikan LE (ed). Drug Therapy in Dermatology. New York: Marcel Dekker, 2000; p 171-233
56. Zouboulis ChC, Seltmann H, Neitzel H, Orfanos CE: Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol 113:1011-1020, 1999